LSA
RIGL icon

Leonteq Securities AG’s Rigel Pharmaceuticals RIGL Stock Holding History

Leonteq Securities AG’s Portfolio RIGL Stock Details RIGL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-450
Closed -$19.3K – 1458
2025
Q4 		$19.3K Buy
+450
New +$17K ﹤0.01% 1105

Other funds holding RIGL

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Leonteq Securities AG's RIGL Position: Q1 2026 in Review

Leonteq Securities AG sold out of Rigel Pharmaceuticals (RIGL) in Q1 2026, closing a stake of 450 shares — an estimated $19.3K sold.

Leonteq Securities AG first reported a position in RIGL in Q4 2025 and held it in 1 quarter. The position peaked at $19.3K in Q4 2025. 159 funds tracked by Wall St. Rank hold RIGL as of Q1 2026.

  • Leonteq Securities AG reported no remaining Rigel Pharmaceuticals position as of Q1 2026 after selling out during the quarter.
  • Leonteq Securities AG sold 450 Rigel Pharmaceuticals shares in Q1 2026, an estimated $19.3K.
  • Leonteq Securities AG first reported a position in Rigel Pharmaceuticals in Q4 2025 and held it in 1 quarter.
  • Leonteq Securities AG's Rigel Pharmaceuticals position peaked at $19.3K in Q4 2025.
  • 159 funds tracked by Wall St. Rank held Rigel Pharmaceuticals as of Q1 2026.

Based on Leonteq Securities AG's 13F filing for Q1 2026, filed 27 Apr 2026.